GSK PLC closed 14.69% below its 52-week high of £17.67, which the company reached on May 31st.

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

Inc., and Vice President at GSK plc (formerly GlaxoSmithKline plc) and Kos Pharmaceuticals, Inc. Notable achievements include building an $800M division at Kos Pharmaceuticals, Inc., helping ...

GlaxoSmithKline Consumer Nigeria Plc has announced plans to shut down its operations in the country. This was disclosed in a press statement issued on Thursday and filed with the Nigerian Exchange ...

GlaxoSmithKline Plc (GSK), a British multinational drug maker and biotechnology company, has announced its intention to end operations in Nigeria. This was made known in a statement signed by the ...

GlaxoSmithKline PLC develops and manufactures innovative vaccines and specialty medications for disease diagnosis, management, and treatment. Research and development (R&D) at GlaxoSmithKline ...

(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) announced the FDA accepted the New Drug Application for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for the potential ...

CCI has approved "acquisition of 100% of the equity share capital of GlaxoSmithKline Asia Private by GlaxoSmithKline Consumer Healthcare Overseas and GlaxoSmithKline Consumer Healthcare UK Trading ...

GlaxoSmithKline PLC announced Thursday an agreement to supply the Government of Canada with 20,000 doses of Sotrovimab, the COVID-19 monoclonal antibody therapy the company developed with Vir ...

GlaxoSmithKline Plc has delivered some good news amid mounting concerns about the omicron variant. Its research showed that sotrovimab, the Covid-19 antibody treatment it developed with Vir ...